COVID-19 Test Kit (Colloidal Gold Method) is a solid phase immunochromatographic assay for the rapid, qualitative detection of antigen to 2019 Novel Coronavirus in human nasal cavity. This test is used to detect nucleocapsid antigen of the SARS-CoV-2 virus in individuals suspected of having COVID-19. This test is an aid for diagnosis of COVID-19 and only provides a presumptive screening test result for the SARS-CoV-2 virus.
This test is authorized for self-test in individuals:
· Aged 18 years or older
· Aged 2-17 who have their tests supervised by a parent or legal guardian
· Who have covid like symptoms within 7 days.
The test must be used with the nasal swab provided in the kit.
INTRODUCTION
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatically infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
PRINCIPLE
The COVID-19 Test Kit (Colloidal Gold Method) is a colloidal gold immunochromatographic assay. It detects the nucleocapsid protein on the surface of COVID-19.
The test uses COVID-19 (SARS-CoV-2) antibody (test line T) and goat anti-chicken IgY (control line C) immobil- ised on a nitrocellulose strip.